HSPA5 and breast cancer: Katherine L. Cook and collaborators showed that GRP78 specifically inhibits de novo fatty acid synthesis in breast cancer cells and reduces mitochondrial β-oxidation through inhibition of mitochondrial carnitine palmitoyltransferase 1a (CPT1a), which catalyses the primary regulated step in overall mitochondrial fatty acid oxidation (Cook et al., 2016).